SC 13D Filing

Company

Olema Pharmaceuticals, Inc.

Filed

December 3, 2020

Accession Number

0000935836-20-000676

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →